HER2/NEU NEGATIVE
Clinical trials for HER2/NEU NEGATIVE explained in plain language.
Never miss a new study
Get alerted when new HER2/NEU NEGATIVE trials appear
Sign up with your email to follow new studies for HER2/NEU NEGATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Breast cancer breakthrough: Surgery-Free option for exceptional responders?
Disease control Recruiting nowThis study is testing whether women with certain types of breast cancer (HER2-positive or triple-negative) who have no cancer left after initial drug therapy can safely skip surgery and just receive radiation. For others with ER-positive/HER2-negative cancer, it tests skipping ra…
Matched conditions: HER2/NEU NEGATIVE
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New hope for hard-to-treat breast cancer: drug combo targets resistance
Disease control Recruiting nowThis study tests whether adding another drug (cediranib or AZD6738) to the PARP inhibitor olaparib can shrink tumors or slow cancer growth in people with advanced BRCA-mutated breast cancer that has stopped responding to PARP inhibitors. About 60 adults with HER2-negative, BRCA-p…
Matched conditions: HER2/NEU NEGATIVE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
Blood test monitoring may be as effective as scans for advanced breast cancer
Knowledge-focused Recruiting nowThis study is testing whether using simple blood tests (tumor markers) to decide when to do scans is as good as the usual approach of regular scans for people with advanced hormone receptor-positive breast cancer. About 739 participants will be randomly assigned to either blood t…
Matched conditions: HER2/NEU NEGATIVE
Phase: NA • Sponsor: SWOG Cancer Research Network • Aim: Knowledge-focused
Last updated May 17, 2026 03:01 UTC